Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1987-10-09
1991-12-10
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
252364, 424 80, 424455, 424456, 5147729, A61K 31765
Patent
active
050716433
ABSTRACT:
This invention relates to a solvent system for enhancing the solubility of an acidic, basic, or amphoteric pharmaceutical agent to produce a highly concentrated solution suitable for softgel filling or two piece encapsulation. The solvent system comprises polyethylene glycol containing 0.2-1.0 mole equivalents of an ionizing agent per mole equivalent pharmaceutical agent and 1-20% water. Glycerin or polyvinylpyrrolidone may be added to further enhance the solubility of certain drugs. The disclosed solvent system is capable of enhancing solubilities of pharmaceutical agents 40-400%.
The ionizing agent functions by causing partial ionization (neutralization) of the free pharmaceutical agent. When the pharmaceutical agent is acidic, the ionizing agent is preferably a hydroxide ion species, whereas when the pharmaceutical agent is basic, the ionizing agent is preferably a hydrogen ion species. For amphoteric pharmaceutical agents, either hydroxide ion or hydrogen ion sources may be utilized to effect partial ionization.
The disclosed solvent system is useful because it not only provides for the enhancement or improvement of bioavailability of acidic, basic and amphoteric pharmaceutical agents by delivering them already in solution, but it also provides for a highly concentrated solution capable of encapsulation in a small enough vessel to permit easy swallowing.
The highly concentrated solid solutions of the present invention are also useful for conversion into tablets and as veterinary spot and pour on preparations.
REFERENCES:
patent: 3557280 (1971-01-01), Weber et al.
patent: 3849549 (1974-11-01), Dempski et al.
patent: 3851051 (1974-11-01), Miskel et al.
patent: 4002718 (1977-01-01), Gardella et al.
patent: 4067960 (1978-01-01), Fadda
patent: 4087547 (1978-05-01), Archer et al.
patent: 4145440 (1979-03-01), Fitch et al.
patent: 4198391 (1980-04-01), Grainger
patent: 4213963 (1980-07-01), Mesens et al.
patent: 4472376 (1984-09-01), Kamishita
patent: 4486412 (1984-12-01), Shah et al.
patent: 4525348 (1985-06-01), Arizono et al.
patent: 4562192 (1985-12-01), Wagner
patent: 4689233 (1987-08-01), Dvorsky
patent: 4690823 (1987-09-01), Lohner et al.
patent: 4701327 (1987-10-01), Henmi et al.
patent: 4708834 (1987-11-01), Cohen et al.
patent: 4713246 (1987-12-01), Begum et al.
patent: 4798725 (1989-01-01), Patel
William Ebert, "Soft Elastic Gelatin Capsules: A Unique Dosage Form", Pharmaceutical Technology, Oct. (1977).
Lachman, L., et al., "The Theory and Practice of Industrial Pharmacy", Chapter 13, pp. 370-376, Publisher, Lea and Febriger (1970).
Osol (ed.) Remington's Pharmaceutical Sciences (16th ed. 1980), pp. 206-207.
Kirk-Orthmer Encyclopedia of Chemical Technology (3rd ed. 1983), vol. 23, pp. 975-976.
Chakrabarti Sibaprasanna
Hom Foo S.
Huang Chong-Heng
Patel Mahendra
Yu Man S.
Lee Lester L.
R. P. Scherer Corporation
LandOfFree
Solvent system enhancing the solubility of pharmaceuticals for e does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Solvent system enhancing the solubility of pharmaceuticals for e, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solvent system enhancing the solubility of pharmaceuticals for e will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1039167